Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03467750 · ClinicalTrials.gov registry record · Phase 4
Effect of Ketorolac on Post Adenotonsillectomy Pain
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 63
- Enrollment target
NCT03467750 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 63 participants.
The verdict
NCT03467750, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 63 participants
- Enrollment target
Study Summary
This randomized prospective study aims to determine the effect of ketorolac on the total dose of morphine required to achieve postoperative analgesia in children with obstructive sleep apnea (OSA) undergoing adenotonsillectomy. Participants will be randomly assigned to a study group where they will receive ketorolac in addition to the standard of care treatment or will receive only the standard of care pain management. The researchers hypothesize that by administering ketorolac at the end of the procedure once hemostasis has been achieved, it will be possible to decrease the amount of morphine administered in the post-anesthesia care unit (PACU). This study aims to provide a more comprehensive understanding of the efficacy and safety of the current standard post-operative analgesic regimen employed at the study institution, in which opioid analgesia currently plays a prominent role.
Interventions
- DRUG Ketorolac
- DRUG Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2018-07-19 |
| Est. Completion | 2023-08-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03467750
The ClinicalTrials.gov registry entry for NCT03467750 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT03467750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03467750 about?
NCT03467750 is a clinical study titled "Effect of Ketorolac on Post Adenotonsillectomy Pain". This randomized prospective study aims to determine the effect of ketorolac on the total dose of morphine required to achieve postoperative analgesia in children with obstructive sleep apnea (OSA) undergoing adenotonsillectomy. Participants will be randomly assigned to a study group where they will ...
What is the current status of trial NCT03467750?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 63 participants. The study started on 2018-07-19. Estimated completion is 2023-08-22.
What interventions are being tested in trial NCT03467750?
The interventions under investigation include: Ketorolac (DRUG), Standard of Care (DRUG).
Who is sponsoring clinical trial NCT03467750?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.